Emerging Excipients in Parenteral Medications The New Paradigm

Emulate the evolutionary egregious targeting mechanisms of certain pathogens the so-called killers as healers model. 

Evade degradation or misdirected delivery by the body s myriad built in defense mechanisms. 

Intuitively such delivery systems or excipients would best achieve this objective if they were to be composed of natural products or their modifications an overwhelming presence of excipients under this category (discussed in Ref. 1) provides credence to this observation. The substitution of natural products comprising complex proteins, antibodies, chimera, or toxins in lieu of stand-alone simple inorganic molecules as excipients for parenteral drug delivery represents a paradigm shift in the introduction of emerging excipients in the therapeutic armamentarium. 

---